When we compared macrophages and FABP4 expression in tumor tissues in patients with or without tumor metastasis (Figure 7E), we showed that tumors from metastatic patients had higher expression of CD163+ macrophages (Figure 7F) and FABP4 expression (Figure 7G). This evidence concerns the gene CD163 and neoplasm.